About the Meeting

The Joint ASTCT + EBMT Basic and Translational Scientific Meeting is a 2.5-day conference focused on cutting-edge basic and translational biology in the field. The meeting focuses on fundamental themes and novel technologies with an emphasis on unpublished and innovative science. Historically, attendance to the meeting is limited to 100 attendees with afternoon breaks to allow for informal networking opportunities between junior and senior attendees. The meeting hosts two days of poster sessions and a best oral abstract session.

Who Should Attend

  • Advanced Practice Providers
  • Hematopathologists
  • Medical and Pediatric Hematologists and Oncologists
  • Oncology Nurses
  • Pharmacists
  • Physicians In Training
  • Translational and Basic Scientists
  • Other Associated Allied Health Professionals

Registration

Registration for the 2025 meeting is now open. 

Register

  Early Bird Standard Late
Category April 16, 2025 May 11, 2025 On-site
Senior Physicians, Scientists, and Researchers 325 € 350 € 400 €
Trainee and Junior Faculty* 180 € 200 € 250 €
Allied Health Professionals** 200 € 200 € 200 €
Industry*** 900 € 900 € 900 €

*Junior attendees are defined as post doctoral fellows, and junior faculty within the first three years of appointment.

**Nurses, pharmacists, nutritionists, therapists, etc.

***Companies not sponsoring the meeting

All cancellations must be electronically mailed or postmarked by using the option "Modify registration".

Registration to this event is limited to a maximum of 100 total attendees. We are unable to accept additional registrants once the registration capacity has been met.

This conference is only for physicians and scientists who are currently practicing in the field of transplantation and cellular therapy and sponsoring companies. Please contact Gemma Puig (fundraising@ebmt.org) if you are interested in participating as a sponsor.

Refund of registration fees will be as follows:

  • In case of cancellation, up until one month prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges).
  • If the cancellation is notified between 15 and 30 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges).
  • Cancellations notified between 1 and 15 day registration fee will not be refunded.

 

Agenda

Day 1: Wednesday, May 14
 
Topic: Fibrosis | Session Chair: Bruce Blazar
9:00 – 9:15 AM Welcome and Introduction
9:15 – 9:40 AM Overview on Fibrosis
Kevin Hart (US)
9:40 – 10:05 AM Immunotherapeutical Targeting of Fibrogenic Cells
Christian Stockmann (CH)
10:05 – 10:30 AM Delineating Clinically Tractable Pathogenic Pathways of Chronic GVHD in Patients
Geoff Hill (US)
10:30 – 11:00 AM Panel Discussion and Q&A
11:00 – 11:30 AM Break
Topic: Genome Editing | Session Chair: Chiara Bonini
11:30 – 11:55 AM TCR-Engineered T Cell Therapy Comes of Age: Generating Safe and Effective Treatments for Acute Myeloid Leukemia
Eliana Ruggiero (IT)
11:55 – 12:20 PM CD45 Gene Editing
Lukas Jeker (CH)
12:20 – 12:45 PM

In Vivo Site-Specific Integrations to Reprogram T Cells
William Nyberg (SE)

12:45 – 1:15 PM Panel Discussion and Q&A
1:15 – 5:15 PM Lunch and Afternoon Networking
Topic: Best Abstracts (I) | Session Chair: Pavan Reddy
5:00 – 5:15 PM High-Resolution Spatial Transcriptomic Analysis of Cutaneous Chronic Graft-Versus-Host Disease Highlights CSF1RintLYZhi Macrophage Infiltration With Aberrant Keratinocyte and Fibroblast Differentiation
Julie Boiko (US)
5:15 – 5:30 PM Rational Modification of Human Gut Microbiome and Metabolites by Dietary Resistant Starch in Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HCT) to Mitigate Acute Graft-Versus-Host Disease (aGVHD): A Phase II Study Clinical and Biological Correlatives Update
Marie Riwes (US)
5:30 – 5:45 PM

Gut-Microbiota Dervied N,N,N-Trimethyl-5-Aminovaleric Acid (TMAVA) is a Modulator of CNS-acute GVHD
Sangya Chatterjee (DE)

5:45 – 6:00 PM The Anti-inflammatory Peptide RLS-0071 (pegtarazimod) Reduces Acute Graft-Versus-Host Disease (aGVHD) by Modulating Immune Cells and Enterocytes
Verena Holzmüller (DE)
5:45 – 6:00 PM Poster Tour + Networking Hour
7:00 – 8:45 PM Dinner Session - Sickle Cell Disease New Developments
Eliane Gluckman (FR)
Day 2: Thursday, May 15
Topic: T-Cell Engineering | Session Chair: Stan Riddell
9:00 – 9:25 AM Understanding T-Cell Antigen Recognition to Inform Designs of T-Cell-Based Therapies - Insights from Molecular Imaging
Johannes Huppa (DE)
9:25 – 9:50 AM Strategies for Improving
Stan Riddell (US)
9:50 – 10:15 AM Engineering Multi-Pronged CAR-T Cells for Cancer Therapy
Yvonne Chen (US)
10:15 – 10:45 AM Panel Discussion and Q&A
10:45 – 11:15 AM Break
Topic: Biology of Relapse | Session Chair: Anna Sureda
11:15 - 11:40 AM The role of NSD2 in high risk t(4;14) associated multiple myeloma 
Jonathan Licht (US)
11:40 – 12:05 PM T-Cell Responses Against Minor Histocompatibility Antigens After Allogeneic Stem Cell Transplantation
Marieke Griffioen (NL)
12:05 – 12:30 PM Title to be announced
José Ángel Martínez Climent (ES)
12:30 – 1:00 PM Panel Discussion and Q&A
1:00 – 5:00 PM Lunch and Afternoon Networking
Topic: Best Abstracts (II) | Session Chair: Nicolaus Kröger
5:00 – 5:15 PM COPII Transport Controls T-Cell Functions by Regulating SREBP-1 Mediated Fatty Acid Metabolism
Yuichi Sumii (US)
5:15 – 5:30 PM Targeting miR-146a to Improve CAR T Cell Therapy
Anna-Sophia Baur (DE)
5:30 – 5:45 PM

Effects of  Post-Transplant Cyclophosphamide on Immune Reconstitution and TCR Repertoire After Haploidentical and HLA-Matched Transplantation Compared to GVHD Prophylaxis With Calcineurin Inhibitor Plus Methotrexate in HLA-matched Transplantation
Michela Ansuinelli (IT)

5:45 – 6:00 PM Timed Targeting of cGAS / STING to Improve Tissue-Regeneration and Anti-Tumor Responses Following Allo-HSCT
Omer Khalid (DE)
6:00 – 7:00 PM Meet-the-Professor Session
7:00 – 8:45 PM Dinner Session - My Journey Developing Virus-Specific T-Cells as Immunotherapy
Cliona Rooney (US)
Day 3: Friday, May 16
Topic: Microbiome | Session Chair: Ami Bhatt
8:00 – 8:25 AM From Precise Microbial Genomics to Precision Medicine
Ami Bhatt (US)
8:25 – 8:50 AM Harnessing Microbial Metabolites for T Cell Therapies
Hendrik Poeck (DE)
8:50 – 9:15 AM Microbiome and transplantation/cell therapies – the search for specific mechanisms
Robert Jenq (US)
9:15 – 9:45 AM Panel Discussion and Q&A
9:45 – 10:00 AM Closing Remarks

Housing

SANA Malhoa Hotel

Av. José Malhoa 8, 1099-089
Lisboa, Portugal

+351 21 006 1800

Registered attendees will receive the housing link to secure discounted room rates in their official registration confirmation email upon availability.

Room Rates

  • Single occupancy: 200€ per night including breakfast, VAT, and service charges.
  • Double occupancy: 220€ per night including breakfast, VAT, and service charges.
  • Municipal Touristic tax per night/person will be charged at the hotel. (2€ in 2024)

Housing Rate Cutoff

To take advantage of the discounted room rate, be sure to book your reservation on or before April 13, 2025. After April 13, the room block will be released and the negotiated room rates may not be available. 

Deposits

Please have your credit card information on hand upon booking your reservation. 

Changes or Cancellations

Please be aware that cancellations will be charged according to the information below

  • Before April 15: No penalty
  • From April 6–24: One night will be charged
  • From April 25 – May 2: 50% of the entire stay will be charged
  • From May 3: 100% of the entire stay will be charged
  • No shows will be charged 100%
  • Any cancellation must be received in writing to the hotel

Confirmations

The hotel will send you a confirmation to the email used in booking your reservation using the customized online reservation link provided by ASTCT-EBMT. Review it carefully for accuracy and keep a copy for your records.